S

Surgical Science Sweden AB
STO:SUS

Watchlist Manager
Surgical Science Sweden AB
STO:SUS
Watchlist
Price: 129.4 SEK 0.7%
Market Cap: 6.6B SEK
Have any thoughts about
Surgical Science Sweden AB?
Write Note

Surgical Science Sweden AB
Research & Development

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Surgical Science Sweden AB
Research & Development Peer Comparison

Comparables:
EKTA B
CEVI
GETI B
ARJO B
S
STIL

Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
S
Surgical Science Sweden AB
STO:SUS
Research & Development
-kr180.9m
CAGR 3-Years
-104%
CAGR 5-Years
-69%
CAGR 10-Years
N/A
Elekta AB (publ)
STO:EKTA B
Research & Development
-kr830m
CAGR 3-Years
-3%
CAGR 5-Years
1%
CAGR 10-Years
N/A
CellaVision AB
STO:CEVI
Research & Development
-kr83.3m
CAGR 3-Years
-48%
CAGR 5-Years
-12%
CAGR 10-Years
-18%
Getinge AB
STO:GETI B
Research & Development
-kr1.1B
CAGR 3-Years
-14%
CAGR 5-Years
-11%
CAGR 10-Years
N/A
Arjo AB (publ)
STO:ARJO B
Research & Development
-kr149m
CAGR 3-Years
-9%
CAGR 5-Years
-1%
CAGR 10-Years
N/A
S
Stille AB
STO:STIL
Research & Development
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Surgical Science Sweden AB's Research & Development?
Research & Development
-180.9m SEK

Based on the financial report for Jun 30, 2024, Surgical Science Sweden AB's Research & Development amounts to -180.9m SEK.

What is Surgical Science Sweden AB's Research & Development growth rate?
Research & Development CAGR 5Y
-69%

Over the last year, the Research & Development growth was 2%. The average annual Research & Development growth rates for Surgical Science Sweden AB have been -104% over the past three years , -69% over the past five years .

Back to Top